Physician profile
Mark J Sherman
NPI 1134147812
$14,765.57
in general payments reported to CMS, 2019-2025
26 companies · $862 in 2025
The $862 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,716 · 2020: $195 · 2021: $268 · 2022: $306 · 2023: $1,566 · 2024: $2,853 · 2025: $862.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,431 · Food and Beverage: $1,849.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,431.26 |
| Food and Beverage | $1,848.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Covidien LP | $5,820.55 | 2019-2020 | |
| Medtronic, INC. | $3,554.91 | 2023-2025 | Progrip, Transorb, Pteye Parathyroid Detection System |
| Heron Therapeutics, INC. | $2,575.48 | 2019 | |
| Davol INC. | $748.09 | 2019-2025 | Phasix Mesh, Channel Drain, Arista Ah Flexitip |
| Tela Bio, INC. | $539.20 | 2019-2025 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Intuitive Surgical, INC. | $377.22 | 2019-2025 | |
| Kerecis Limited | $238.92 | 2022 | |
| Stryker Corporation | $168.74 | 2025 | Spy-Phi System |
| Ethicon US, LLC | $130.05 | 2019-2024 | Echelon Flex, Ethicon, Echelon Endopath |
| Allergan, INC. | $103.55 | 2019-2021 | |
| Abbvie INC. | $63.57 | 2024 | |
| Endogastric Solutions, INC | $63.26 | 2024 | Esophyx |
| Elucent Medical | $57.43 | 2025 | |
| Conmed Corporation | $42.29 | 2019-2024 | Airseal |
| Getinge USA Sales, LLC | $36.20 | 2024 | Ultima Activator II Drive Mechanism |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $31.17 | 2023 | Gattex |
| Acelrx Pharmaceuticals, INC. | $29.28 | 2019 | |
| Ge Healthcare | $27.71 | 2024 | |
| Boston Scientific Corporation | $24.73 | 2022 | |
| Innocoll Pharmaceuticals Limited | $24.40 | 2021 | |
| Aroa Biosurgery Incorporated | $23.00 | 2022 | |
| Tactile Systems Technology INC | $20.08 | 2025 | Nimbl, Flexitouch Plus |
| Acera Surgical, INC. | $18.64 | 2025 | Restrata Wound Matrix |
| Innovation Technologies INC | $17.95 | 2024 | Irrisept |
| Braintree Laboratories, INC. | $14.66 | 2024 | Sutab, Suflave |
| Baxter Healthcare | $14.49 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Sherman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.